Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma

Overview of attention for article published in Oncotarget, December 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 7,734 followers.

#PaperoftheDay: "Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma" https://t.co/F5dVD5dHBZ #squamous #oncology #openaccess #science #medicine #medEd #OA

RT @Oncotarget: #PaperoftheDay: "Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma" https:/…

RT @Oncotarget: #PaperoftheDay: "Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma" https:/…

#PaperoftheDay: "Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma" https://t.co/F5dVD5dHBZ #oralcancer #openaccess #oncology #science #medicine #medEd #OA